Methylphenidate hydrochloride Extended-Release ablets USP — Class II drug recall D-0836-2020
Terminated recall by Teva Pharmaceuticals USA, reported 2020-02-19, distributed nationwide. CGMP deviations: Product bottle may be absent of desiccant.
| Recall number | D-0836-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, Parsippany, NJ, United States |
| Recall initiated | 2020-01-27 |
| Classified | 2020-02-10 |
| Reported by FDA | 2020-02-19 |
| Terminated | 2020-11-03 |
| Distributed | Nationwide (US) |
| Reason classes | cgmp |
| NDC | 62037-0725, 62037-0725-01, 62037-0726, 62037-0726-01, 62037-0727, 62037-0727-01, 62037-0734, 62037-0734-01 |
| Lot numbers | 1332796A |
| Expiration dates | 2020-11 |
Product
Methylphenidate hydrochloride Extended-Release ablets USP (CII), 18 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 62037-725-01
Reason for recall
CGMP deviations: Product bottle may be absent of desiccant.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0836-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.